SABRINAH JACKSON: Open Payments
NPI 1962287102 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 18 payments from 7 companies in 2025. Trend: 2023 $82 · 2024 $795 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $165 |
| ABBVIE INC. | 4 | $101 |
| Alkermes, Inc. | 3 | $56 |
| Tris Pharma Inc | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: Auvelity, VRAYLAR, ARISTADA, Dyanavel XR, AUSTEDO XR, FANAPT, INGREZZA.
Industry payments across TX — which companies pay providers there.
